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Abstract:  
A set of water-soluble CdTe quantum dots (QDs) was prepared by the chemical reaction between cadmium 
chloride and sodium hydrogen telluride in the presence of 3-mercaptopropionic acid (MPA). QDs were 
characterized using fluorescence spectroscopy, lifetime measurements, slab-gel and capillary electrophoresis. 
The particle sizes, determining the wavelength of the fluorescence emission, were evaluated to be from 2.5 nm 
(500 nm) to 5.2 nm (750 nm). The fluorescence lifetimes determined by the time-resolved fluorescence 
spectrometry, increases from 3.05 to 20.5 ns with the increasing size of particles. The uptake of non-conjugated 
QDs into the living cells, which has a potential for single cell analyses, was apparent for human lymphocytes and 
yeast cells (Saccharomyces cerevisiae) after 30 minutes and 3 hours, respectively. The cell manipulation, lysis 
and monitoring was performed in microfluidic devices with laser-induced fluorescence detection. The 
conjugation of QDs with functional biomolecules allows the selective labeling and localization of specific 
molecules. Several coupling agents such as N-hydroxysulfosuccinimide (NHS) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) or carbonyldiimidazole (CDI) were used. The 




Semiconductor quantum dots (QDs) are bright 
fluorescent nanocrystals in the size range from 1 to 
10 nm. QDs consist of semiconductor central core 
stabilized by shell, mainly from inorganic salts (e.g. 
CdS, ZnS) [1]. Water-solubility is provided by 
charged compounds covalently attached to the surface 
of QDs via thiol groups [2]. The molecules attached 
to the outer shell serve as mediator for the 
conjugation with functional ligands or biomolecules 
[3, 4]. Due to their unique optical properties, such as 
sharp and symmetric emission spectra, high quantum 
yield of fluorescence, good chemical stability, 
practically no photobleaching [5-8] and emission 
wavelength dependent on the nanoparticle size [2], 
QDs are becoming attractive as alternative 
fluorescent labels in analytical chemistry, cell biology 
and medicine. Various methods are used for 
characterization of QDs size and structure, e.g. 
transmission electron microscopy [9-11], atomic 
force microscopy [12], analytical centrifugation [13], 
X-ray photoelectron spectroscopy or powder 
diffraction [9, 10, 14], dynamic light scattering [15] 
and fluorescence correlation spectroscopy [16] and 
electrophoretic methods including capillary 
electrophoresis (CE).  
The QDs conjugates with functional biomolecules 
(e.g. proteins, DNA, antibodies or enzymes) are used 
in immunoassays [17, 18], cellular labeling [19, 20], 
single-molecule/cell tracking [21, 22], deep-tissue 
imaging [4, 23] and as a fluorescence resonance 
energy transfer donors [4, 24, 25]. There are several 
possibilities for QDs connection with functional 
biomolecules. It should be electrostatic or 
hydrophobic attractions [26-28], avidin-biotin 
interactions [27, 29], direct interactions with QD 
surface [25, 30, 31], and the most frequently used, 
covalent bonding [6, 15, 17, 19]. Zero cross-linkers 
such as 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) or carbonyldiimidazole (CDI) 
and two step procedure combining EDC with 
sulfosuccinyl imide (NHS), are used for bonding QDs 
with biomolecule via peptide bond [32]. 
This work is focused on the survey of methods for the 
preparation, physico-chemical characterization and 
conjugation of CdTe QDs and their application in cell 
analyses. The different sizes CdTe nanoparticles 
stabilized by 3-mercaptopropionic acid (MPA) were 
synthesized. Their excitation and emission spectra 
and fluorescence lifetimes were measured. The 
uptake time of non-conjugated QDs by human 
lymphocytes and Saccharomyces cerevisiae was 
followed using epifluorescence microscope. 
Consequently, the QDs were conjugated with 
antibody and the possibility of selective labeling of 
cells and the time of the uptake were tested. 
EXPERIMENTAL 
Chemicals and reagents 
The following chemicals were used for the 
preparation of QDs: NaBH4 (98.5 %), tellurium 
powder (99.8 %), CdCl2 (99.99 %) 3-
mercaptopropionic acid (99 %), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride 
(EDC) and N-hydroxysulfosuccinimide (NHS) (98.5 
%) from Fluka. The monoclonal Anti-CD3 antibody 
 was purchased from Sigma-Aldrich (St. Luis, MO, 
USA). 
Preparation and conjugation of CdTe quantum 
dots  
CdTe quantum dots were prepared using reaction 
between cadmium chloride, natrium hydrogen 
telluride at the presence of 3-mercaptopropionic acid 
(MPA) with the molar ratio CdCl2 : NaHTe : HS–
CH2–CH2-COOH = 2 : 1 : 4.8 according to procedure 
described by Li et al. [14]. Briefly, the natrium 
hydrogen telluride was prepared by the reaction of 
84.85 mg natrium borohydride with 126.97 mg 
tellurium powder and 2 ml of deionized water. The 
reaction mixture was set to the ice cubes and stirred 
for approximately 4 hours. After this time, 2 ml of the 
dark violet solution of NaHTe was transferred to 
boiling flask with 80 ml deionized water, degassed 
with N2 for 30 minutes, 370 mg CdCl2 and 420 µl 
MPA. The pH of the created red solution was 
adjusted to 7.0 using 0.1 mol/l NaOH or MPA. The 
reaction mass was heated under the reflux condenser. 
MPA coated QDs were conjugated with antibodies 
containing primary amino groups by reaction with 
NHS and EDC coupling agents which mediate the 
formation of peptide bond between carboxylic group 
and amino group [32-35]. The main reason of 
utilization of EDC was its water solubility and 
chemical stability. The purpose of adding sulfo-NHS 
to EDC is to increase the stability of the active 
intermediate at pH range from 5 to 7.3 [32]. In fact, a 
mixture of 10 µl QDs (10-4 M), 2 µl EDC solution 
(60 mg/ml) and 10 µl NHS (0.15 mg/ml) reacted in an 
Eppendorf microtube for 30 minutes. Finally, 20 µl of 
the antibody solution were added and the mixture was 
left at a room temperature for 2 hours. 
Fluorescence and lifetime measurements 
Fluorescence spectra were measured on Aminco-
Bowman AB-2 (Thermo Spectronic, NY, USA) with 
continuous 150 W xenon lamp. Life-time 
measurements were done on a home made 
instrument. Sample was excited by 6 mW 266 nm 
Nd:YAG laser (LCS-DTL-382QT, Laser – compact 
Co. Ltd., Moscow, Russia). Fluorescence was 
collected by reflective objective 25-0522-190 (Ealing 
Catalog Inc., Rocklin, CA, USA) with magnification 
36x, scattered laser light was removed by long pass 
filters 269 nm and 295 nm (Omega Optical, Inc., 
Brattleboro, VT, USA). Fluorescence was detected by 
photomultiplier tube H5783-03 (Hamamatsu 
Photonics K.K., Iwata City, Japan). The output signal 
was collected by digital oscilloscope WaveRunner 
6050 (LeCroy, New York, NY, USA) with software 
version 5.0.0.2 and XStream Browser version 1.0.3. 
RESULTS AND DISCUSSIONS 
Preparation and characterization of CdTe QDs 
MPA coated CdTe QDs were synthesized according 
to method described by Li et all [14]. The size and 
emission maximum of nanoparticles should be easily 
controlled and different sizes of QDs can be prepared 
during one synthesis. The refluxing time of last 
reaction stage determine the size and emission 
maximum of rising nanoparticles [14]. Several 
samples were taken during refluxing in different 
times. The fluorescence spectra of these samples were 
measured and emission maxima and bandwidths were 
determined. The excitation spectra of different 
samples were practically the same with a breadth of 
300 – 550 nm. The refluxing time was in the range 
from 10 minutes for the smallest 2.5 nm nanoparticles 
with the emission maximum of 500 nm to 44 hours 
for 5.2 nm particles with the emission maximum of 
750 nm (Fig. 1). The emission bandwidth of the 
prepared nanoparticles increased from 45 nm to 100 
nm with increasing the refluxing time and size.  
The fluorescence lifetime, characteristic of 
fluorophores frequently used in analytical chemistry, 
was determined using time-resolved fluorescence 
spectroscopy. It was found out that fluorescence 
lifetimes of QDs vary from 3.05 to 20.5 ns with their 
increasing size. The shortest lifetime, which belongs 
to 2.0 nm particles, is similar to low molecular mass 
fluorophores, e.g. fluorescein (3.8 ns). 
The narrow emission together with the broad 
excitation spectra are advantageous for parallel 
analyses of several analytes labeled by different QDs 
sizes. Thus, it is not necessary to use several different 
light sources for the excitation of particular 
fluorescent probe but only a single light source is 
satisfactory. The resistance against photobleaching 
allows for repetitive observations and long collection 




Fig. 1: Fluorescence emission spectra of QDs prepared for different 
refluxing time (normalized spectra) 
Non-selective labeling of cells 
The uptake of QDs by different types of cells was 
studied. Whenever QDs conjugated with 
biomolecules will be used for the selective and 
specific labeling of analytes in the cell, it is necessary 
 to know the uptake of non-conjugated QDs. Human 
lymphocytes and Saccharomyces cerevisiae cells 
were selected as model cells. Human lymphocytes 
and Saccharomyces cerevisiae represent cells 
sensitive to changes in their environment. Cells were 
mixed with QDs and its uptake was monitored under 
epifluorescence microscope. The uptake was apparent 
after 3 hours and 30 minutes for yeasts and 
lymphocytes, respectively (Fig. 2). 
 
 
Fig. 2: Uptake of QDs into Saccharomyces cerevisiae cells (A) and 
human lymphocytes (B)  
Selective labeling of cells 
The QDs were conjugated via EDC and NHS 
coupling agents with CD3 antibody. This is the 
antibody against CD3 protein specific for T-
lymphocytes while B-lymphocytes do not contain this 
membrane protein. CD3 antibody was conjugated 
with QDs and fluorescein. These conjugates were 
added to a mixture of T- and B-lymphocytes. 
Sufficient labeling was apparent immediately after 
mixing in the case of T-lymphocytes (Fig. 3 A and 
B). In the case of B-lymphocytes no labeling was 




Fig. 3: Human T-lymphocytes labeled by QD-antiCD3 conjugate 
(A), T-lymphocyte labeled by fluorescein-antiCD3 conjugate (B), 
no interaction of B-lymphocyte with QD-antiCD3 conjugate (C). 
CONCLUSIONS 
The set of different sizes of CdTe nanoparticles 
coated with MPA was synthesized and characterized 
by fluorescence spectra and lifetimes. The size range 
of prepared nanoparticles was from 2.5 nm with 
emission maximum 500 nm to 5.2 nm with emission 
maximum 750 nm. The lifetimes of these QDs vary 
from 3.05 ns to 20.5 ns with increasing size of 
nanoparticles. Nanoparticles with emission maximum 
610 nm were conjugated with CD3 antibody to 
selectively label T-lymphocytes. The selectivity of 
labeling was confirmed via adding QD-antiCD3 
conjugate to the mixture of T- and B- lymphocytes 
where only T-lymphocytes were labeled immediately. 
Non-selective labeling of human lymphocytes and 
Saccharomyces cerevisiae with MPA coated QDs 
was tested. It was found out that the uptake of non-
conjugated QDs is 30 min and 3 h for human 
lymphocytes and Saccharomyces cerevisiae, 
respectively. 
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